Virus
19
2
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
1 terminated out of 19 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (19)
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
TTV Viral Load in Heart Transplant Recipients
Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)
Microbes and Respiratory Illnesses
TARGet Kids! COVID-19 Study of Children and Families
Genetic Determinants of the Antiviral Immune Response in Oceanian Populations
Edinburgh and Lothian Virus Intervention Study in Kids
Effects of Photobiomodulation on the Innate Immune System of Neonates and Infants With Bronchiolitis
The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study
Hand Sanitizer Use for Herpes Simplex Virus-1
Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study
Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma
COVID-19 Diagnostic Self-testing Using Virtual Point-of-care
Borderline COVID-19 PCR Test Result
The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
Using PRP and Cord Blood in Treatment of Covid -19
Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
Western Equine Encephalitis Vaccine, Inactivated